Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KDU 731

Next Previous
Drug Profile

KDU 731

Alternative Names: ABO-809; EDI-048; KDU-731

Latest Information Update: 03 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis; University of Georgia; Washington State University
  • Developer Novartis
  • Class Antiparasitics; Pyrazolones; Pyridines; Small molecules
  • Mechanism of Action 1-phosphatidylinositol 4-kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Cryptosporidiosis

Most Recent Events

  • 03 Jul 2025 Phase I development for Cryptosporidiosis (In volunteers) is ongoing in the US and United Kingdom (PO) (Novartis pipeline, July 2025)
  • 18 Dec 2024 Novartis completes a phase I trial in Cryptosporidiosis (In volunteers) in United Kingdom (PO) (ISRCTN38693215) (NCT05275855)
  • 27 Dec 2022 Novartis completes a phase I trial in Cryptosporidiosis (In volunteers) in USA (PO) (NCT05036668)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top